全文获取类型
收费全文 | 12252篇 |
免费 | 854篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 148篇 |
儿科学 | 326篇 |
妇产科学 | 143篇 |
基础医学 | 1784篇 |
口腔科学 | 187篇 |
临床医学 | 1078篇 |
内科学 | 2446篇 |
皮肤病学 | 170篇 |
神经病学 | 1319篇 |
特种医学 | 521篇 |
外国民族医学 | 1篇 |
外科学 | 1918篇 |
综合类 | 109篇 |
一般理论 | 4篇 |
预防医学 | 849篇 |
眼科学 | 277篇 |
药学 | 1102篇 |
中国医学 | 44篇 |
肿瘤学 | 738篇 |
出版年
2023年 | 71篇 |
2022年 | 118篇 |
2021年 | 216篇 |
2020年 | 164篇 |
2019年 | 226篇 |
2018年 | 278篇 |
2017年 | 163篇 |
2016年 | 207篇 |
2015年 | 266篇 |
2014年 | 345篇 |
2013年 | 522篇 |
2012年 | 765篇 |
2011年 | 830篇 |
2010年 | 499篇 |
2009年 | 464篇 |
2008年 | 785篇 |
2007年 | 831篇 |
2006年 | 826篇 |
2005年 | 835篇 |
2004年 | 789篇 |
2003年 | 697篇 |
2002年 | 664篇 |
2001年 | 178篇 |
2000年 | 123篇 |
1999年 | 164篇 |
1998年 | 165篇 |
1997年 | 130篇 |
1996年 | 119篇 |
1995年 | 101篇 |
1994年 | 84篇 |
1993年 | 88篇 |
1992年 | 115篇 |
1991年 | 98篇 |
1990年 | 81篇 |
1989年 | 102篇 |
1988年 | 64篇 |
1987年 | 64篇 |
1986年 | 77篇 |
1985年 | 81篇 |
1984年 | 74篇 |
1983年 | 73篇 |
1982年 | 64篇 |
1981年 | 58篇 |
1980年 | 44篇 |
1979年 | 38篇 |
1978年 | 29篇 |
1977年 | 31篇 |
1975年 | 30篇 |
1973年 | 35篇 |
1972年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation 总被引:3,自引:0,他引:3
Michel Carrier MD Michel White MD Louis P. Perrault MD PhD Guy B. Pelletier MD Michel Pellerin MD Danielle Robitaille MD L. Conrad Pelletier MD 《The Journal of heart and lung transplantation》1999,18(12):1395-1223
BACKGROUND: Intravenous thymoglobuline (125 mg a day for 3 days, Institut Mérieux, France) has been used to induce immunosuppression following heart transplantation. Cyclosporine and prednisone, with and without azathioprine or mycophenolate mofetil were used as maintenance immunosuppression. OBJECTIVE: The objective of the study was to determine the clinical effect of antibody induction of immunosuppression following heart transplantation. METHODS: A retrospective analysis of the clinical experience at the Montreal Heart Institute. From 1988 to 1998, 163 patients were administered a 3-day course of intravenous thymoglobuline immediately following heart transplantation (Group 1). From 1983 to 1987 and during an isolated period in 1994, intravenous and oral cyclosporine was used immediately following heart transplantation in 48 patients (Group 2). Routine endomyocardial biopsies were performed in all patients and only moderate and severe rejection was treated. RESULTS: One, 5- and 10-year actuarial survival rate averaged 85%+/-3, 77%+/-4 and 67%+/-5 in Group 1 compared with 88%+/-5, 81%+/-6 and 76%+/-6 in Group 2 (p = 0.5). At 1 year, the freedom rate from an episode of acute rejection averaged 43%+/-4 in Group 1 and 30%+/-7 in Group 2 (p = 0.03) and the freedom rate from an episode of infection averaged 44%+/-4 in Group 1 and 31%+/-7 in Group 2 (p = 0.2). At 1, 5 and 10 years, the freedom rate from graft coronary artery disease averaged 93%+/-2, 68%+/-5 and 50%+/-7 in Group 1 compared with 93%+/-4, 58%+/-8 and 30%+/-8 in Group 2 (p = 0.1) and the freedom rate from cancer averaged 98%+/-1, 91%+/-3 and 67%+/-8 in Group 1 compared with 100%, 95%+/-3 and 77%+/-8 in Group 2 (p = 0.2). There was no side-effect related to the systemic injection of thymoglobuline. CONCLUSION: In a cyclosporine based protocol of immunosuppression, induction with an initial 3-day course of intravenous thymoglobuline is associated with a lower rate of acute rejection. Moreover, the risk of infection and of developing cancer is not increased whereas there was a trend towards a lower incidence of coronary atherosclerosis 5 and 10 years after transplantation. 相似文献
992.
Greg Zaharchuk Alastair J Martin Guy Rosenthal Geoffery T Manley William P Dillon 《Magnetic resonance in medicine》2005,54(1):113-121
Fluid-attenuated inversion recovery (FLAIR) images obtained during the administration of supplemental oxygen demonstrate a hyperintense signal within the cerebrospinal fluid (CSF) that is likely caused by T1 changes induced by paramagnetic molecular oxygen. Previous studies demonstrated a linear relationship between the longitudinal relaxation rate (R1 = 1/T1) and oxygen content, which permits quantification of the CSF oxygen partial pressure (P(csf)O2). In the current study, CSF T1 was measured at 1.5 T in the lateral ventricles, third ventricle, cortical sulci, and basilar cisterns of eight normal subjects breathing room air or 100% oxygen. Phantom studies performed with artificial CSF enabled absolute P(csf)O2 quantitation. Regional P(csf)O2 differences on room air were observed, from 65 +/- 27 mmHg in the basilar cisterns to 130 +/- 49 mmHg in the third ventricle. During 100% oxygen, P(csf)O2 increases of 155 +/- 45 and 124 +/- 34 mmHg were measured in the basilar cisterns and cortical sulci, respectively, with no change observed in the lateral or third ventricles. P(csf)O2 measurements in humans breathing room air or 100% oxygen using a T1 method are comparable to results from invasive human and animal studies. Similar approaches could be applied to noninvasively monitor oxygenation in many acellular, low-protein body fluids. 相似文献
993.
994.
T-24.B-cell differentiation factor induces immunoglobulin secretion in human B cells without prior cell replication 总被引:1,自引:0,他引:1
Stimulation of B lymphocytes from B-cell chronic lymphocytic leukaemia (B-CLL) with 12-0-tetradecanoylphorbol-13-acetate (TPA) has shown that these cells are capable of differentiation (Totterman, Nilsson & Sundstrom, 1980). Increases in the expression of different class II MHC antigens (Guy et al., 1983, 1986) and responsiveness to growth factors (Kabelitz et al., 1985; Suzuki, Butler & Cooper, 1985) have been studied. Supernatant from the human bladder carcinoma line T-24 contains a B-cell differentiation factor (BCDF) able to induce immunoglobulin secretion from CESS cells. We investigated the induction of proliferation and immunoglobulin secretion in human B cells by studying the effects of this factor on B-CLL cells, in both the presence and absence of TPA. We report here that this material (termed T-24.BCDF) causes immunoglobulin secretion to be initiated in these cells, and that this is not accompanied by detectable DNA synthesis. These observations were extended to normal human B cells and demonstrate that human B cells can secrete immunoglobulin in the absence of clonal expansion. 相似文献
995.
We have developed a mathematical model of the regulation of ventilation that successfully simulates breathing in the awake as well as in sleeping states. In previous models, which were used to simulate Cheyne-Stokes breathing and respiration during sleep, the controller was only responsive to chemical stimuli, and allowed no ventilation at sub-normal carbon dioxide levels. The current model includes several new features. The chemical controller responds continuously to changes in P(CO(2)) with a lower sensitivity during hypocapnia than in the hypercapnic ranges. Hypoxia interacts multiplicatively with P(CO(2)) over the entire range of activity. The controller in the current model, besides the chemical drive, includes also a neural component. This neural drive increases and decreases as the level of alertness changes, and adds or subtracts from ventilation levels demanded by the chemical controller. The model also includes the effects of post-stimulus potentiation (PSP) and hypoxic ventilatory depression (HVD). While PSP eliminates apneas after a disturbance and also dampens the subsequent dynamics of the respiration, it is not a major factor in the damping of the response. Another finding is that HVD is destabilizing. The model is the first to reproduce results reported in conscious humans after hyperventilation and after acute and longer-term hypoxia. It also reproduces the effects of NREM sleep. 相似文献
996.
997.
Cyril Gitiaux MD Emmanuel Roze MD PhD Kiyoka Kinugawa MD Constance Flamand‐Rouvière ST Nathalie Boddaert MD PhD Emmanuelle Apartis MD PhD Vassili Valayannopoulos MD Guy Touati MD Jacques Motte MD PhD David Devos MD PhD Karine Mention MD Dries Dobbelaere MD PhD Diana Rodriguez MD PhD Agathe Roubertie MD PhD Brigitte Chabrol MD PhD François Feillet MD PhD Marie Vidailhet MD Nadia Bahi‐Buisson MD PhD 《Movement disorders》2008,23(16):2392-2397
998.
Sandra Wiedersberg Richard H. Guy 《European journal of pharmaceutics and biopharmaceutics》2009,71(2):362-366
The objective was to compare the in vivo distribution profiles of betamethasone 17-valerate (BMV) across the stratum corneum (SC) following (a) delivery from gelled and un-gelled formulations, and (b) two different skin cleaning procedures at the end of the application period. BMV was dissolved in gelled and un-gelled vehicles comprising either medium chain triglycerides (MCT) or a brand microemulsion (ME). The BMV concentration was adjusted to 80% of saturation and applied to the forearms of healthy volunteers. After 2 h, the treated skin site was cleaned either with a dry paper towel or with an isopropyl alcohol swab, and the SC was then progressively removed by repeated adhesive tape-stripping. BMV distribution profiles across the SC showed reasonable reproducibility, and that delivery from the ME was significantly superior to that from MCT. Gelled vehicles were less efficiently removed from the skin surface by dry wiping than un-gelled formulations. Removing excess formulation more aggressively with isopropyl alcohol resulted in a lower apparent uptake of drug into the SC. Excess gelled formulation may be trapped in the skin ‘furrows’, and requires an efficient skin cleaning procedure to ensure its complete removal. 相似文献
999.
1000.